
09/22/2025
This is a good thing.
GLP-1 receptor agonists may alter how people experience food, new EASD 2025 data show. One study linked therapy to reduced “food noise,” while another found shifts in taste perception, adding insight into how incretin-based therapies influence appetite and eating behavior. http://ms.spr.ly/6181sWqrD